Preview

Педиатрическая фармакология

Расширенный поиск

Особенности формирования эпидермального барьера и применение эмолентов у недоношенных и детей раннего возраста

https://doi.org/10.15690/pf.v16i4.2054

Полный текст:

Аннотация

В статье представлены современные данные об особенностях строения кожи и формирования эпидермального барьера у недоношенных и детей раннего возраста. Приведены сведения, касающиеся изменений свойств кожного покрова — микрорельефа, гидратации, трансэпидермальной потери воды, кислотности, содержания естественного увлажняющего фактора, секреции кожного сала. Также уделено внимание роли сыровидной смазки в образовании зрелого эпидермального барьера и приведены данные об использовании смягчающих/увлажняющих средств.

Об авторах

Н. Н. Мурашкин
Национальный медицинский исследовательский центр здоровья детей; Первый Московский государственный медицинский университет им. И.М. Сеченова (Сеченовский Университет); Центральная государственная медицинская академия Управления делами Президента Российской Федерации
Россия

Контактная информация: Мурашкин Николай Николаевич, доктор медицинских наук, профессор, заведующий отделением дерматологии с группой лазерной хирургии ФГАУ «Национальный медицинский исследовательский центр здоровья детей» Минздрава России

Адрес: 119991, Москва, Ломоносовский пр-т, д. 2


Р. А. Иванов
Национальный медицинский исследовательский центр здоровья детей
Россия
Москва


А. А. Савелова
Национальный медицинский исследовательский центр здоровья детей
Россия
Москва


Д. В. Федоров
Национальный медицинский исследовательский центр здоровья детей
Россия
Москва


Л. А. Опрятин
Национальный медицинский исследовательский центр здоровья детей
Россия
Москва


В. Ахмад
Кабардино-Балкарский государственный университет им. Х.М. Бербекова
Россия
Кабардино-Балкарская Республика


Список литературы

1. Oranges T, Dini V, Romanelli M. Skin physiology of the neonate and infant: clinical implications. Adv Wound Care (New Rochelle). 2015;4(10):587–595. doi: 10.1089/wound.2015.0642.

2. Fluhr JW, Darlenski R, Lachmann N, et al. Infant epidermal skin physiology: adaptation after birth. Br J Dermatol. 2012;166(3):483– 490. doi: 10.1111/j.1365-2133.2011.10659.x.

3. Fernandes JD, Machado MC, Oliveira ZN. Children and newborn skin care and prevention. An Bras Dermatol. 2018;86(1):102–110. doi: 10.1590/s0365-05962011000100014.

4. Nepalia A, Mathur N, Singh A. An overview of the harmful additives and contaminants possibly present in baby cosmetic products. Int J Chem Sci. 2017;15(2):127.

5. Sharma S, Hani Y. Anatomy, Skin (Integument), Epidermis. 2017;8:141.

6. Boer M, Duchnik E, Maleszka R, Marchlewicz M. Structural and biophysical characteristics of human skin in maintaining proper epidermal barrier function. Postepy Dermatol Alergol. 2016;33(1):1–5. doi: 10.5114/pdia.2015.48037.

7. Kubo A, Nagao K, Amagai M. Epidermal barrier dysfunction and cutaneous sensitization in atopic diseases. J Clin Invest. 2012;122(2):440–447. doi: 10.1172/JCI57416.

8. Evans NJ, Rutter N. Development of the epidermis in the newborn. Biol Neonate. 1986;49(2):74–80. doi: 10.1159/000242513.

9. Kalia YN, Nonato LB, Lund CH, Guy RH. Development of skin barrier function in premature infants. J Invest Dermatol. 1998;111(2):320–326. doi: 10.1046/j.1523-1747.1998.00289.x.

10. Telofski LS, Morello AP, Mack Correa MC, Stamatas GN. The infant skin barrier: can we preserve, protect, and enhance the barrier? Dermatol Res Pract. 2012;2012:198789. doi: 10.1155/2012/198789.

11. Stamatas GN, Nikolovski J, Mack MC, Kollias N. Infant skin physiology and development during the first years of life: a review of recent findings based on in vivo studies. Int J Cosmet Sci. 2011;33(1):17–24. doi: 10.1111/j.1468-2494.2010.00611.x.

12. Fluhr JW, Darlenski R, Taieb A, et al. Functional skin adaptation in infancy — almost complete but not fully competent. Exp Dermatol. 2010;19(6):483–492. doi: 10.1111/j.1600-0625.2009.01023.x.

13. Pickens WL, Warner RR, Boissy YL, et al. Characterization of vernix caseosa: water content, morphology, and elemental analysis. J Invest Dermatol. 2000;115(5):875–881. doi: 10.1046/j.15231747.2000.00134.x.

14. Visscher MO, Narendran V, Pickens WL, et al. Vernix caseosa in neonatal adaptation. J Perinatol. 2005;25(7):440–446. doi: 10.1038/sj.jp.7211305.

15. Darmstadt GL, Mao-Qiang M, Chi E, et al. Impact of topical oils on the skin barrier: possible implications for neonatal health in developing countries. Acta Paediatr. 2002;91(5):546–554. doi: 10.1080/080352502753711678.

16. Stamatas GN, Nikolovski J, Luedtke MA, et al. Infant skin microstructure assessed in vivo differs from adult skin in organization and at the cellular level. Pediatr Dermatol. 2010;27(2):125–131. doi: 10.1111/j.1525-1470.2009.00973.x.

17. Sriram G, Bigliardi PL, Bigliardi-Qi M. Fibroblast heterogeneity and its implications for engineering organotypic skin models in vitro. Eur J Cell Biol. 2015;94(11):483–512. doi: 10.1016/j.ejcb.2015.08.001.

18. Blume-Peytavi U, Hauser M, Stamatas GN, et al. Skin care practices for newborns and infants: review of the clinical evidence for best practices. Pediatr Dermatol. 2012;29(1):1–14. doi: 10.1111/j.1525-1470.2011.01594.x.

19. Giusti F, Martella A, Bertoni L, Seidenari S. Skin barrier, hydration, and pH of the skinof infants under 2 years of age. Pediatr Dermatol. 2001;18(2):93–96. doi: 10.1046/j.15251470.2001.018002093.x.

20. Visscher MO, Adam R, Brink S, Odio M. Newborn infant skin: physiology, development, and care. Clin Dermatol, 2015, 33: 271– 280. Clin Dermatol. 2015;33(3):271–280. doi: 10.1016/j.clindermatol.2014.12.003.

21. Hoeger PH, Schreiner V, Klaassen IA, et al. Epidermal barrier lipids in human vernix caseosa: corresponding ceramide pattern in vernix and fetal skin. Br J Dermatol. 2002;146(2):194–201. doi: 10.1046/j.1365-2133.2002.04584.x.

22. Nikolovski J, Stamatas GN, Kollias N, Wiegand BC. Barrier function and water-holding and transport properties of infant stratum corneum are different from adult and continue to develop through the first year of life. J Invest Dermatol. 2008;128(7):1728–1736. doi: 10.1038/sj.jid.5701239.

23. Visscher M. Infant skin research. In: Second annual joint meeting of the International Society of Bioengineering and the skin and the International Society for Skin Imaging. Philadelphia, PA; 2005.

24. Agache P, Blanc D, Barrand C, Laurent R. Sebum levels during the first year of life. Br J Dermatol. 1980;103(6):643–649. doi: 10.1111/j.1365-2133.1980.tb01686.x.

25. Hoeger PH, Enzmann CC. Skin physiology of the neonate and young infant: a prospective study of functional skin parameters during early Pediatr Dermatol. 2002;19(3):256–262. doi: 10.1046/j.1525-1470.2002.00082.x.

26. Houben E, Hachem JP, De Paepe K, Rogiers V. Epidermal ceramidase activity regulates epidermal desquamation via stratum corneum acidification. Skin Pharmacol Physiol. 2008;21(2):111–118. doi: 10.1159/000114872.

27. Puhvel SM, Reisner RM, Sakamoto M. Analysis of lipid composition of isolated human sebaceous gland homogenates after incubation with cutaneous bacteria. Thin-layer chromatography. J Invest Dermatol. 1975;64(6):406–411. doi: 10.1111/1523-1747.ep12512337.

28. Mauro T, Holleran WM, Grayson S, et al. Barrier recovery is impeded at neutral pH, independent of ionic effects: implications for extracellular lipid processing. Arch Dermatol Res. 1998;290(4):215– 222. doi: 10.1007/s004030050293.

29. Matousek JL, Campbell KL. A comparative review of cutaneous pH. Vet Dermatol. 2002;13(6):293–300. doi: 10.1046/j.13653164.2002.00312.x.

30. Scientific dossier Mustela: new discoveries on infant skin from the first days of life [Publié le 4 avr. 2014. Available from: https://fr.slideshare.net/MustelaMedical/dossier-scientifique-nouvellesdcouvertes-sur-la-peau-saine-du-bb.

31. Kelleher MM, O’Carroll M, Gallagher A, et al. Newborn transepidermal water loss values: a reference dataset. Pediatr Dermatol. 2013,30(6):712–716. doi: 10.1111/pde.12106.

32. Levin J, Maibach H. The correlation between transepidermal water loss and percutaneous absorption: an overview. J Control Release. 2005;103(2):291–299. doi: 10.1016/j.jconrel.2004.11.035.

33. Wilson DR, Maibach HI. Transepidermal water loss in vivo. Premature and term infants. Biol Neonate. 1980;37(3–4):180– 185. doi: 10.1159/000241271.

34. Sedin G, Hammarlund K, Nilsson GE, et al. Water transport through the skin of newborn infants. Ups J Med Sci. 1981;86(1):27– 31. doi: 10.3109/03009738109179207.

35. Saijo S, Tagami H. Dry skin of newborn infants: functional analysis of the stratum corneum. Pediatr Dermatol. 1991;8(2):155–159. doi: 10.1111/j.1525-1470.1991.tb00308.x.

36. Yosipovitch G, Maayan-Metzger A, Merlob P, Sirota L. Skin barrier properties in different body areas in neonates. Pediatrics. 2000;106(1 Pt 1):105–108. doi: 10.1542/peds.106.1.105.

37. Rutter N, Hull D. Water loss from the skin of term and preterm babies. Arch Dis Child. 1979;54(11):858–868. doi: 10.1136/adc.54.11.858.

38. Hirao T, Terui T, Takeuchi I, et al. Ratio of immature cornified envelopes does not correlate with parakeratosis in inflammatory skin disorders. Exp Dermatol. 2003;12(5):591–601. doi: 10.1034/j.1600-0625.2003.00007.x.

39. Jiang YJ, Lu B, Crumrine D, et al. IL-1alpha accelerates stratum corneum formation and improves permeability barrier homeostasis during murine fetal development. J Dermatol Sci. 2009;54(2):88– 98. doi: 10.1016/j.jdermsci.2009.01.001.

40. Kusari A, Han AM, Virgen CA, et al. Evidence-based skin care in preterm infants. Pediatr Dermatol. 2019;36(1):16–23. doi: 10.1111/pde.13725.

41. Darmstadt GL, Saha SK, Ahmed AS, et al. Effect of skin barrier therapy on neonatal mortality rates in preterm infants in Bangladesh: a randomized, controlled, clinical trial. Pediatrics. 2008;121(3):522–529. doi: 10.1542/peds.2007-0213.

42. Bharathi M, Sundaram V, Kumar P. Skin barrier therapy and neonatal mortality in preterm infants. Pediatrics. 2009;123(2):e355; author reply e355-6. doi: 10.1542/peds.2008-2307.

43. Darmstadt GL, Badrawi N, Law PA, et al. Topically applied sunflower seed oil prevents invasive bacterial infections in preterm infants in Egypt: a randomized, controlled clinical trial. Pediatr Infect Dis J. 2004;23(8):719–725.

44. Al-Kharfy T, Ba-Abbad R, Hadi A, Al-Faleh K. Use of topical petroleum jelly for prevention of sepsis in very low-birthweight infants: a prospective, randomised controlled trial. Paediatr Int Child Health. 2014;34(3):194–197. doi: 10.1179/2046905514Y.0000000117.

45. Campbell JR, Zaccaria E, Baker CJ. Systemic candidiasis in extremely low birth weight infants receiving topical petrolatum ointment for skin care: a case-control study. Pediatrics. 2000;105(5):1041–1045. doi: 10.1542/peds.105.5.1041.

46. Conner JM, Soll RF, Edwards WH. Topical ointment for preventing infection in preterm infants. Cochrane Database Syst Rev. 2004;(1):CD001150. doi: 10.1002/14651858.CD001150.pub2.

47. Kanti V, Grande C, Stroux A, et al. Influence of sunflower seed oil on the skin barrier function of preterm infants: a randomized controlled trial. Dermatology. 2014;229(3):230–239. doi: 10.1159/000363380.

48. Kiechl-Kohlendorfer U, Berger C, Inzinger R. The effect of daily treatment with an olive oil/lanolin emollient on skin integrity in preterm infants: a randomized controlled trial. Pediatr Dermatol. 2008;25(2):174–178. doi: 10.1111/j.1525-1470.2008.00627.x.

49. Bonifaz A, Rojas R, Tirado-Sánchez A, et al. Superficial mycoses associated with diaper dermatitis. Mycopathologia. 2016;181(9– 10):671–679. doi: 10.1007/s11046-016-0020-9.

50. Blume-Peytavi U, Kanti V. Prevention and treatment of diaper dermatitis. Pediatr Dermatol. 2018;35 Suppl 1:s19–s23. doi: 10.1111/pde.13495.

51. Simpson EL, Berry TM, Brown PA, Hanifin JM. A pilot study of emollient therapy for the primary prevention of atopic dermatitis. J Am Acad Dermatol. 2010;63(4):587–593. doi: 10.1016/j.jaad.2009.11.011.

52. Simpson EL, Chalmers JR, Hanifin JM, et al. Emollient enhancement of the skin barrier from birth offers effective atopic dermatitis prevention. J Allergy Clin Immunol. 2014;134(4):818–823. doi: 10.1016/j.jaci.2014.08.005.

53. Wollenberg A, Szepietowski J, Taieb A, Ring J. Corrigendum: consensus-based European guidelines for treatment of atopic eczema (atopic dermatitis) in adults and children: part I. J Eur Acad Dermatol Venereol. 2019;33(7):1436. doi: 10.1111/jdv.15719.

54. LePoidevin LM, Lee DE, Shi VY. A comparison of international management guidelines for atopic dermatitis. Pediatr Dermatol. 2019;36(1):36–65. doi: 10.1111/pde.13678.

55. Koppes SA, Charles F, Lammers L, et al. Efficacy of a cream containing ceramides and magnesium in the treatment of mild to moderate atopic dermatitis: a randomized, double-blind, emollientand hydrocortisone-controlled trial. Acta Derm Venereol. 2016;96(7):948–953. doi: 10.2340/00015555-2395.


Для цитирования:


Мурашкин Н.Н., Иванов Р.А., Савелова А.А., Федоров Д.В., Опрятин Л.А., Ахмад В. Особенности формирования эпидермального барьера и применение эмолентов у недоношенных и детей раннего возраста. Педиатрическая фармакология. 2019;16(4):241-247. https://doi.org/10.15690/pf.v16i4.2054

For citation:


Murashkin N.N., Ivanov R.A., Savelova A.A., Fedorov D.V., Opryatin L.A., Ahmad W. Features of the Formation of the Epidermal Barrier and the Use of Emollients in Premature and Young Children. Pediatric pharmacology. 2019;16(4):241-247. (In Russ.) https://doi.org/10.15690/pf.v16i4.2054

Просмотров: 57


Creative Commons License
Контент доступен под лицензией Creative Commons Attribution 4.0 License.


ISSN 1727-5776 (Print)
ISSN 2500-3089 (Online)